Johan Reutfors: Risk factors and consequences in difficult-to-treat depression – results from Swedish registry studies

No registration required.

Welcome to the Sahlgrenska Academy Science Seminars, a series of seminars on Thursdays at 15-16. This seminar will be conducted in Assembly room Birgit Thilander at Academicum and online through zoom webinar.

Here is the link to the webinar: https://gu-se.zoom.us/j/69490970108

The seminars are open to anyone interested in taking part of scientific breakthroughs and projects in the medicine and health science field. Scientists, students and other staff from GU, VGR and other organisations with the common interest of medicine and health science, welcome!

Speaker: Johan Reutfors, Associate Professor and senior physician, Centre for Pharmacoepidemiology, KI

Topic:

Up to half of the patients who start treatment for depression are still depressed after two treatment attempts. This is commonly called difficult-to-treat or treatment-resistant depression (TRD). This presentation will give an overview of current knowledge about TRD and how national Swedish registers can be used for research on the condition. Our research on the relationship between TRD and mortality, substance use, disability pension, and healthcare consumption, as well as recently published findings on the treatment effect of ECT in TRD compared to other depression, will be presented.

Host: Erik Pålsson, dep. of Neuroscience and Physiology, SA

Welcome!

Upcoming seminars

Flyer program Sahlgrenska Academy Science Seminars

Do you wish to sign up for an email reminder of the Sahlgrenska Science Seminars about one hour before it starts?

Send an email to research.support@sahlgrenska.gu.se

Topic: Reminder Sahlgrenska Academy Science Seminars